Internationa Journal of Bolg! Macromolecles 253 (2024) 190296
Contents lists available at SsienceDicect
International Journal of Biological Macromolecules
ELSEVIER Journal homepage: www.elsevier.comilocatellibiomac
Review ®
A review on natural biopolymers in external drug delivery systems for eat
wound healing and atopic dermatitis
Patricia C. Pires®'*‘, Fouad Damiri®", Ehsan Nazarzadeh Zare“', Anwarul Hasan", Rasoul
Esmaeely Neisiany , Francisco Veiga”, Pooyan Makvandi *", Ana Cléudia Paiva-Santos °"""*
Departmen of Paracel Tec, cy of Pharmacy of th Unies of Cina, Univesity of Coimbra, Cin, Porn
‘ meqUmTe: 14g, rp of Pharmac Tene, acy of Pharma fh Um ef Cara, Unverstyof Camb, Cra, Parag
“Heth Sac Rae Cnre (CICS UBD, Une of ara arr fee Hon, 200 308 Cah Papa
"etree of Bont cd Org Sy (IOSHNTHC), Depart f Cem, Fao Scene Ben W'S, Unvsty Hanon of Ceca,
‘Sth of chesty, Danghn Univer, Danghan 2671645567, an
“Ca of Rach np and Ona, Chiara ners, pre 140401, Punch, nie
Dipurman of Mehl on nr ageing. Qu Ue, Dot 2713, Qaar
* moneda! Reseach Gone, dar Unie, Doh 2713, aur
orn Can, sun Unveayof echo Arse 8 44100 vice, Pant
Depart fle gcrigHaki Sb Uo, Soe 961707687, on
"afr Bog Schon of Bog The Urey of ante. gh OK
tars Care fr Roach and Devan, Cire Unser, Himachal Pra 14103, Ia
© Dgwtmen of Brats Soe Dew Calg nd Paps STMATS, Sete Unies, Cha 0007, ie
* Chae an ierig Reset Tam (RSC), Deparment of Chery, Paar acy of Ben Mal PBN, Uber Slr Moy
‘Simare (USS), Bo Moll 2300, ar,
ARTICLE INFO AesTRACT
Kegwote Despte the advantages of opel admielstvation nthe weatment of hin dlseases, current marketed preparations
polymer foe the challenge ofthe skin's barr effec, leacing to low therapeutic effectiveness and undesirable side ef
® feos. Hence, in recent years the management of skin wounds, the main morbidty-cavsing complication in
hospital environments, and atopic dermatitis, the mest common inflammatory skin disease, has beeome 2 great
concer. Fortunately, new, more efetive, and safer treatments are alreay underdevelopment, with chitosan,
starch, sik ibroin, agarose, hyaluronic ac, alisate, collagen, and gelatin having been sed forthe develop.
ment ofanoparices,ipesore, noses and/or hydrogels improve he deliver of several molecules forthe
treatment ofthese diseases, Biocompatity,bioderadabily, increased viscosity, controlled érug dlvery,
Increased drug retention inthe epidermis, ad overall mitigation of adverse ees, conrbute to an efective
trentment,aditonally proving intrinsic antimirobial and wound healing properties In this review, some of
the most reent success eases of bopolymerbased dru delivery systems as part of panocarriers semisolid
hydenge! matrices, oF both (hyd system, forthe management af sin wounds nd atopic demas are
‘rtcallydisetaed, including compotion and vite er vive and in vve chararteiation, showing the prose
ofthese external drug delivery stems
1. Introduction
1.1, Overview: Background and significance
‘The treatment of skin diseases through topical drug administration
7 Gorapondence tA. Hasan, Department of Mechanical and indus Engineering, Qata Univerty, Doha 2713, Qatar.
** Cowespondence te: AC. PavaSantes, Department of Pharmaceutical Techoolgy, Faculty of Pharmacy f the University of Coimbra, Unversity of Coimbra,
Coimbra, Portal
‘Bal eres: basin anarul mie @ymallcom (A, Hasan), acsantost wc pt (AC. Pave Santos)
np//doLorg/10.1036/}Jbiomac.2024.130296
Received 17 Novernber 2028 Received in revised form 14 February 2024; Accepted 17 February 2024
“Available online 19 Ferry 2024
(0141-8130/6 2024 Publised by Eseier RV.offers significant advantages compared to systemic routes. These ad-
vantages include targeted drug delivery, minimized systemic drug
‘expose (and, consequently, fewer systemic side-effects), and avoid
ance of hepatic rst-pas effect [1-3]. Topical formulations are also easy
[Abbreviations
AD Atopic dermatitis
AgNPs Silver nanoparticles
BMV betamethasone 17-valerate
CHX —Chlorhexicine
CMA carboxymethyl agarose
DDS Drug delivery system
DEV lifucortolone valerate
HA Hyaluronic Acid
HC Hydrocortisone
HINTS Halloysite clay nanotubes
HT Hydroxytyrosol
NP Nanoparticle
‘TEWL Transepidermal water loss
20 NPs tine oxide nanoparticles
and painless to administer (non invasiveness), ensuring good patient
compliance. They can be tailored to have controlled drug release,
leading to therapeutic effects tat las for a longer peri of time [>]
"Nevertheless, marketed preparations face considerable challenges, ince
‘the skin's barrier effect makes ic difficult for drugs to permeate it, with
‘existing therapies having lack of effectiveness, need of repeated dosing,
and local as well a systemic side effects [5-8]. Hence, the developmen
‘of new, more effective, and safer treatments is greatly needed
‘Among the various diseases and injuries that can affect the skin,
atopic dermatitis (AD) and wounds have become a growing concern, not
‘only fo patients bt also for healtheare profesional [9,10]. AD is the
‘mst common inflammatory cutaneous disease, being characterized by a